BioSpace News Archive

NERVTEX’s MoDAS (Movement Dysfunction Assessment Software) system, which is a First-in-Class Artificial Intelligence/Machine Learning (AI/ML)- based Software as a Medical Device(SaMD) for the analysis of motor symptoms of Parkinson’s disease and other movement disorders, has been approved by the China National Medical Products Administration, making it the first video-based AI-powered medical device for the assessment of movement disorders.

Zynex, Inc. (NASDAQ: ZYXI) today reported it will be hosting a blood donation drive on February 1, 2023 at its headquarters in Englewood, CO in partnership with Vitalant, the nation’s largest independent, nonprofit blood services provider.

Nikon Instruments Inc. announced the Nikon Spatial Array Confocal detector for AX systems.

City of Hope, one of the largest cancer research and treatment organizations in the United States, announced that its subsidiary, Cancer Treatment Centers of America®, will fully transition its clinical locations to City of Hope’s brand.

Both the US Skokie and European Rankweil sites address customer needs in early-phase drug development

PharmaTher Holdings Ltd. (the “Company” or “PharmaTher”) (OTCQB: PHRRF) (CSE: PHRM), a leader in advancing specialty ketamine pharmaceuticals, today submitted its meeting package with the U.S. Food and Drug Administration (“FDA”) to discuss advancing KETARX™ (racemic ketamine) into Phase 3 development as a treatment for levodopa-induced dyskinesia in Parkinson’s disease (“LID-PD”).

Medigene AG announced the appointment of Pamela Keck as Vice President, Head of Investor Relations and Corporate Communications.

Los Angeles Cancer Network, one of the leading cancer and blood disorder centers in Los Angeles County is proud to announce that board-certified hematologist-oncologist Thomas F Reynolds, MD, FACP, has officially joined it’s growing network.

Rapid Dose Therapeutics Corp. (“RDT” or the “Company”) (CSE: DOSE), has filed its financial results for the first three quarters of the 2023 fiscal year.

Dynatronics Corporation, a leading manufacturer of athletic training, physical therapy, and rehabilitation products, announced that it will effect a 1-for-5 reverse stock split of its outstanding common stock, effective at 5:00 p.m. on February 1, 2023.